Pfizer PGN 50 (Lyrica 50 mg)
Generic Name: pregabalin
Pill imprint Pfizer PGN 50 has been identified as Lyrica 50 mg.
Lyrica is used in the treatment of neuropathic pain; fibromyalgia; diabetic peripheral neuropathy; neuralgia; postherpetic neuralgia (and more), and belongs to the drug class gamma-aminobutyric acid analogs. Risk cannot be ruled out during pregnancy. Lyrica 50 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- Pfizer PGN 50
- 50 mg
- 16.00 mm
- Prescription only
- Drug Class:
- Gamma-aminobutyric acid analogs
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 5 - Some potential for abuse
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose monohydrate
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|33261-0521||Aidarex Pharmacuticals, LLC (repackager)|
|68258-7045||Dispensing Solutions Inc. (repackager)|
|68071-0365||Nucare Pharmaceuticals Inc (repackager)|
|16590-0503||Stat RX USA LLC (repackager)|
|33358-0228||CorePharma, LLC (repackager)|
|52959-0891||H.J. Harkins Company, Inc (repackager)|
|18837-0083||Innoviant Pharmacy Inc (repackager)|
|21695-0277||Rebel Distributors Corp (repackager)|
|49999-0949||Lake Erie Medical and Surgical Supply (repackager)|
|68387-0660||Keltman Pharmaceuticals Inc (repackager)|
|55289-0969||PDRX Pharmaceuticals Inc (repackager)|
|58016-0362||Southwood Pharmaceuticals Inc (repackager)|
|54868-5494||Physicians Total Care Inc (repackager)|
|54569-8704||A-S Medication Solutions, LLC (repackager)|
Note: Inactive ingredients may vary.
More about Lyrica (pregabalin)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.